Treatment of actinic cheilitis with imiquimod 5% and a retractor on the lower lip: Clinical and histological outcomes in 5 patients

British Journal of Oral and Maxillofacial Surgery

Volumn 48, Issue 6, 2010, Pages 473-476

  McDonald, Christopher ^a   Laverick, Sean ^a   Fleming, Colin J ^a   White, Sharon J ^a,b  

^a NINEWELLS HOSPITAL   (United Kingdom)

^b DUNDEE DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

Author keywords

Actinic cheilitis; Dysplasia; Imiquimod; Lip retractor; Lip shave

Indexed keywords

IMIQUIMOD;

ACTINIC CHEILITIS; ARTICLE; CHEILITIS; CLINICAL ARTICLE; CREAM; DYSPLASIA; HISTOLOGY; HUMAN; HUMAN TISSUE; LIP BIOPSY; RETRACTOR; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; AMINOQUINOLINES; CHEILITIS; DENTAL INSTRUMENTS; HUMANS; INTERFERON INDUCERS; OFF-LABEL USE; SUNLIGHT;

EID: 77955981210     PISSN: 02664356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjoms.2009.08.024     Document Type: Article

References (13)

1. I. van der Waal Potentially malignant disorders of the oral and oropharyngeal mucosa: terminology, classification, and present concepts of management Oral Oncol 45 2009 317 323
2. A.S. Cavalcante, A.L. Anbinder, and Y.R. Carvalho Actinic cheilitis: clinical and histological features J Oral Maxillofac Surg 66 2008 498 503
3. G.E. Kaugars, T. Pillion, J.A. Svirsky, D.G. Page, J.C. Burns, and L.M. Abbey Actinic cheilitis. A review of 152 cases Oral Surg Oral Med Oral Path Oral Radiol Edod 88 1999 181 186
4. M.F. Zide Actinic keratosis: from the skin to the lip J Oral Maxillofac Surg 66 2008 1162 1176
5. R. Rossi, G. Assad, G. Buggiani, and T. Lotti Photodynamic therapy: treatment of choice for actinic cheilitis? Dermatol Ther 21 2008 412 415
6. T.K. Eigentler, A. Kamin, B.M. Weide, H. Breuninger, U.M. Caroli, and M. Mohrle A phase III, randomised, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma J Am Acad Dermatol 57 2007 616 621
7. J. Jorizzo, S. Dinehart, R. Matheson, J.K. Moore, M. Ling, and M.S. Fox Vehicle-controlled, double blind, randomised study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratosis on the head J Am Acad Dermatol 57 2007 265 268
8. F.I. Ezughah, A.G. Affleck, A. Evans, S. Ibbotson, and C. Fleming Confirmation of histological clearance of superficial basal cell carcinoma with multiple serial sectioning and Mohs' micrographic surgery following treatment with imiquimod 5% cream J Dermatol Treat 19 2008 156 158
9. M.L. Spenny, J. Walford, A.E. Werchniak, V. Beltrani, J.B. Brennick, and C.A. Storm Lentigo maligna (melanoma in situ) treated with imiquimod cream 5%: 12 case reports Cutis 79 2007 149 152
10. K. Spieth, A. Kovacs, M. Wolter, R. Bug, R. Kaufmann, and J. Gille Topical imiquimod: effectiveness in intraepithelial melanoma of oral mucosa Lancet Oncol 7 2006 1036 1037
11. J. Zhu, K. Lai, R. Brownile, L.A. Babiuk, and G.K. Mutwiri Porcine TLR8 and TLR7 are both activated by a selective TLR7 ligand, imiquimod Mol Immunol 45 2008 3238 3243
12. M. Schiller, D. Metze, T.A. Luger, S. Grabbe, and M. Gunzer Immune response modifiers - mode of action Exp Dermatol 15 2006 331 341
13. K.J. Smith, M. Germain, J. Yeager, and H. Skelton Topical 5% imiquimod for the therapy of actinic cheilitis J Am Acad Dermatol 47 2002 497 501